Predicting the unpredictable during pregnancy

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Could everyday hospital equipment be the next defence against counterfeit medicines?

23 February 2026 A new study suggests the equipment already found in hospitals worldwide could offer a front line against fake vaccines and insulin.

Medtech

Danaher moves to acquire Masimo in $9.9bn deal

18 February 2026 The science and technology conglomerate’s big diagnostics bet comes with monitoring technology, an AI-powered product pipeline, and a litigation history that has kept Silicon Valley’s biggest player on the back foot.

Medtech

Chinese invisible braces maker hits back at infringement claims

22 August 2025 The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.

More features

Could everyday hospital equipment be the next defence against counterfeit medicines?

Danaher moves to acquire Masimo in $9.9bn deal

Rooted in rights: Lessons from plant patent infringement and invalidity cases

$5.4bn medtech leader fails to bury a rival's patent

ITC to probe Oura Ring after Samsung retaliates, seeking import ban

Italian medtech startup beats larger US rival in UPC dispute

How AI will be shaped by legal and regulatory developments in 2026

Key EU and UK regulatory changes to watch for in 2026

Predicting the unpredictable during pregnancy

More on this story

Editor's picks

Editor's picks

More features